THE PRESENT INVENTION RELATES TO NALMEFENE FOR USE IN THE REDUCTION OF ALCOHOL CONSUMPTION IN A PATIENT WITH ALCOHOL DEPENDENCE WHO HAS A HIGH DRINKING RISK LEVEL. THE PRESENT INVENTION ALSO RELATES TO NALMEFENE FOR USE IN THE REDUCTION OF ALCOHOL CONSUMPTION IN A PATIENT WITH ALCOHOL DEPENDENCE WHO MAINTAINS A HIGH DRL AFTER AN OBSERVATION PERIOD FOLLOWING INITIAL ASSESSMENT. FIGURE 4B